Medicare Part B proposals too broad and could hurt patients, groups say

In a letter sent Thursday, 316 healthcare and patient advocacy groups urged leaders in both houses of Congress to ask the Centers for Medicare & Medicaid Services to withdraw its proposal for new Medicare Part B payment models. They argue that the payment models that CMS wants to test should have been implemented in a "targeted, patient-centered and transparent way that accounts for the unique needs of Medicare beneficiaries," instead of the agency's plan to test the models nationwide and on a majority of Part B drugs. As they are proposed, the new payment models could adversely affect patients with complex conditions such as cancer, macular degeneration, hypertension, rheumatoid arthritis, Crohn's disease and ulcerative colitis, and primary immunodeficiency diseases, the letter says. Letter

Suggested Articles

Sixteen medical professionals, including six doctors and seven pharmacists, were among those charged in a Texas healthcare fraud and opioid takedown.

Blue Shield of California is piloting transportation benefits with some of its members in Sacramento.

The healthcare impacts of climate change cost more than $10 billion in the U.S. in 2012 alone, a new analysis found.